Xtrackers Nordic Net Zero Pathway Paris Aligned UCITS ETF 1C (GBP) | XNZNRegister to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | - | - | 4.0 | |
+/-Cat | - | - | - | - | -0.3 | |
+/-B’mrk | - | - | - | - | -2.5 | |
Category: Nordic Equity | ||||||
Category Benchmark: Morningstar Nordic TME NR EUR |
Key Stats | ||
Closing Price 26/04/2024 | GBX 2889.25 | |
Day Change | 1.89% | |
Morningstar Category™ | Nordic Equity | |
Volume | 0 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | IE000HT7E0B1 | |
Fund Size (Mil) 25/04/2024 | EUR 164.38 | |
Share Class Size (Mil) 25/04/2024 | EUR 164.38 | |
Ongoing Charge 22/06/2023 | 0.15% |
Investment Objective: Xtrackers Nordic Net Zero Pathway Paris Aligned UCITS ETF 1C (GBP) | XNZN |
The investment objective of the Fund is to track the performance before fees and expenses of an index which is designed to reflect the performance of companies of the Nordic countries that are selected and weighted with the aim of seeking alignment with EU Paris-aligned Benchmark (“EU PAB”) standards and certain net zero frameworks. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Not Disclosed 12/04/2023 | ||
Inception Date 12/04/2023 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
Solactive ISS ESG Nor IU NZP NR EUR | Morningstar Nordic TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Xtrackers Nordic Net Zero Pathway Paris Aligned UCITS ETF 1C (GBP) | XNZN | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 10.31 |
Zealand Pharma A/S | Healthcare | 2.83 |
Investor AB Class B | Financial Services | 2.58 |
Coloplast A/S Class B | Healthcare | 2.53 |
Novonesis AS Class B | Basic Materials | 2.51 |
Increase Decrease New since last portfolio | ||
Xtrackers Nordic Net Zero Pathway Paris Aligned UCITS ETF 1C (GBP) | XNZN |